• Publications
  • Influence
The effects of 8-year pamidronate treatment on skeletal morbidity in patients with advanced multiple myeloma
Background . In patients with multiple myeloma (MM) osteolytic bone destruction progresses despite a reduction of tumor mass achieved with chemotherapy. The aim of the study was to evaluate theExpand
  • 6
  • 1
The value of the barium enema in the diagnosis of acute appendicitis.
Contrary to popular belief, the barium enema is a safe diagnostic tool in the management of acute appendicitis. This is a survey of our experience over three years with 489 cases of suspected acuteExpand
  • 51
Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).
Osteolytic bone destruction, caused by the aberrant production and activation of osteoclasts, results in significant morbidity for patients with multiple myeloma (MM). PamidronateExpand
  • 15
Effect of pamidronate on skeletal morbidity in myelomatosis. Part 1. The results of the first 12 months of pamidronate therapy.
BACKGROUND Osteolytic bone destruction caused by increase of osteolytic activity is a major manifestation of multiple myeloma (MM). Pamidronate (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate)Expand
  • 14
[A case of congenital situs inversus of the spleen].
[Bone cysts and pseudotumor bone changes in hemophilia].